or
forgot password
  • cancer clinical trials in miles city, MT

  • S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Multiple Myeloma
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Melanoma (Skin)
    S9912 Combination Chemo in Stage III Ovarian Cancer,
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Bladder Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Breast Cancer, Osteoporosis
    Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Pain, Unspecified Adult Solid Tumor, Protocol Specific
    S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Penile Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Eastern Montana Cancer Center
    Miles City, Montana 59301
    Pancreatic Cancer